Adrenocortical Carcinoma Treatment Market Size, Epidemiology, Drugs Pipeline, Market Analysis and Companies by DelveInsight
Adrenocortical Carcinoma (ACC) is rare cancerthat originates in the outer layer of the adrenal gland. ACC is also called cancer of the adrenalcortex. A tumor of the adrenal cortex may be functioning (produces surplus hormones thanusual) or nonfunctioning (does not produce surplus hormones than usual). Mostadrenocortical tumors are functioning. The hormones made by functioning tumors may cause sure signs or symptoms of the disease;the common symptoms caused by ACC include a lump in the abdomen, pain in the abdomenor back, and feeling of fullness in the abdomen.
DelveInsight's "Adrenocortical
Carcinoma Market Insights, Epidemiology, and Market
Forecast-2032" report delivers an in-depth understanding of the
Adrenocortical Carcinoma, historical and forecasted epidemiology as well as the
Adrenocortical Carcinoma market trends in the United States, EU5 (Germany,
Spain, Italy, France, and United Kingdom) and Japan.
Some facts of Adrenocortical
Carcinoma Market Report
·
According to the retrospective review conducted
by Aspinall et al. titled “How is Adrenocortical Cancerbeing Managed in the
UK?,” the incidence of ACC is 0.5‒2 per million per year.
·
According to the study by Johanssen et al.
titled “Deficits in the Management of Patients With Adrenocortical Carcinoma in
Germany,” the incidence of ACC is one per million population, and females are
more frequently affected than males, with a female:male ratio of 1.5 : 1.
·
As per the article by Libé et al. titled
“Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment,” the
incidence of ACC are 0.7‒2 cases per million population per year. It is
reported to be more commonplace females (55–60%) than males.
·
As per the article by Hammer et al. titled
“Adrenal Cortical Carcinoma,” ACC has an incidence of less than one per million
per year with female dominance and peak occurrence in the 4th‒5th decade of life.
Patients present in one of three ways, symptoms of hormone excess (40%),
abdominal pain/fullness or flank pain (40%), or as an incidental finding as
part of an unrelated workup (20%).
·
According to Wang et al. (2017), Adrenocortical Carcinoma
is more common in females than males.
View Report: https://www.delveinsight.com/report-store/adrenocortical-carcinoma-market
To know more the
Adrenocortical Carcinoma Report. Request for sample page here @ https://www.delveinsight.com/sample-request/adrenocortical-carcinoma-market
Scope of the Adrenocortical
Carcinoma Market Report
- The
report covers the descriptive overview of Adrenocortical Carcinoma,
explaining its causes, signs and symptoms, pathophysiology, diagnosis and
currently available therapies
- Comprehensive
insight has been provided into the Adrenocortical Carcinoma epidemiology
and treatment in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for
Adrenocortical Carcinoma is provided, along with the assessment of new
therapies, which will have an impact on the current treatment landscape
- A
detailed review of the Adrenocortical Carcinoma market; historical and
forecasted is included in the report, covering drug outreach in the 7MM
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the global Adrenocortical
Carcinoma market
Some of Adrenocortical
Carcinoma Companies are:
·
Exelixis
·
Enterome
·
And Many Others
Adrenocortical
Carcinoma Therapies are:
·
Cabozantinib
·
EO2401
·
And Many Others
View Report: https://www.delveinsight.com/report-store/adrenocortical-carcinoma-market
To know about the
Adrenocortical Carcinoma pipeline analysis and key companies. Request for
sample page here @ https://www.delveinsight.com/sample-request/adrenocortical-carcinoma-market
Table of Contents:
1. Key Insights
2. Executive Summary
of Adrenocortical Carcinoma
3. Competitive
Intelligence Analysis for Adrenocortical Carcinoma
4. Adrenocortical
Carcinoma: Market Overview at a Glance
5. Adrenocortical
Carcinoma: Disease Background and Overview
6. Patient Journey
7. Adrenocortical
Carcinoma Epidemiology and Patient Population
8. Treatment
Algorithm, Current Treatment, and Medical Practices
9. Adrenocortical
Carcinoma Unmet Needs
10. Key Endpoints of
Adrenocortical Carcinoma Treatment
11. Adrenocortical
Carcinoma Marketed Products
List to be continued
in report
12. Adrenocortical
Carcinoma Emerging Therapies
List to be continued
in report
13. Adrenocortical
Carcinoma: Seven Major Market Analysis
14. Attribute
analysis
15. 7MM: Market
Outlook
16. Access and
Reimbursement Overview of Adrenocortical Carcinoma
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight
Capabilities
22. Disclaimer
DelveInsight’s Competitive
Intelligence Service includes a multidimensional coverage, helping to
keep track of competitors and gain traction in the dynamic market by overcoming
the challenges and expediting business growth through a strategic and tactical
approach.
Some of Newly Launched Report:
- Ventilator
Market
- Apraxia
Market
- Autonomic
Dysfunction Market
- Allergic
Rhinoconjunctivitis Market
- Breast
Pumps Market
- Biochips
Market
- Artificial
Iris Market
- Urolithiasis
Market
- Acute
Coronary Syndrome Market
- Brain
Aneurysm Stents Market
- Pediatric
Growth Hormone Deficiency Pghd Market
- Eczema
Market
- Rituximab
Biosimilars Insight
- Bone
Grafts And Substitutes Market
- Bile
Duct Neoplasm Market
- Emesis
Market
- Pulmonary
Hypertension Associated With Interstitial Lung Disease Market
- Ranibizumab
Biosimilar Insight
- Adrenocortical
Carcinoma Market
- Advanced
Hepatocellular Carcinoma with CPB Liver Cirrhosis Market
- Advanced
Recurrent Ovarian Cancer Market
- Age-Related
Macular Degeneration Market
- Alopecia
Aerata Market
- Anal
Cancer Market
- Anaphylaxis
Market
- Angioedema
Market
- Anti-GBM
disease Market
- Antiphospholipid
Syndrome (APS) Market
- Interbody
Cages Market
- Osteoarthritis
Market
Latest Blogs:
- Robotic
Surgery
- Neuroprosthetics
Market to Reach USD 11.32 Billion, What Are the Driving Factors Behind
It?
- Most
Promising Oncological
Drugs Expected to Launch in 2022
- Cybersecurity
in Healthcare: Major Threats and Challenges
- The
Evolving Neurofibromatosis Treatment Landscape
- Pompe
Disease: Causes, Symptoms, Diagnosis, Pathology, Current Marketed and
Emerging Drugs in the Pipeline
- Social
Determinants of Health and their Impact on COVID-19
- Top
Drugs To Watch in HIV (2025)
- Gene
Therapy for Hemophilia: Progress and Setbacks
About Delveinsight:
DelveInsight Business Research is a leading Market Research, and
Business Consultant focused purely on Healthcare. It helps pharma companies by
providing them with end-to-end services to solve their business problems.
Get hold of all the Pharma and healthcare market research
reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Connect With Us at:
Comments
Post a Comment